Dr. David J. Benjamin, MD

Dr. Benjamin practices at Hoag Hospital Newport Beach in Newport Beach, California, part of Hoag Memorial Hospital Presbyterian.

Dr. Benjamin's NPI, 1821450396, was assigned on March 24, 2016. Dr. Benjamin graduated from Tulane School of Medicine in 2016. Dr. Benjamin holds California license A151232.

Dr. Benjamin's primary practice is Hoag Hospital Newport Beach, at One Hoag Drive, Newport Beach, CA 92663 in Orange County. The practice phone is (949) 764-4624. Dr. Benjamin also practices at Hoag Hospital Newport Beach, 1 Hoag Dr, Newport Beach, CA 92663.

Dr. Benjamin's primary practice is Hoag Hospital Newport Beach in Newport Beach, California, part of Hoag Memorial Hospital Presbyterian. Dr. Benjamin is also affiliated with UCI Health - Orange. The medical group on file is Hoag Clinic. Dmand AI also links Dr. Benjamin to 1 more home health agency, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Benjamin practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Benjamin's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Benjamin is board certified in internal medicine by the American Board of Internal Medicine. Dr. Benjamin is licensed in California.

Dmand AI lists chronic anemia, lung cancer, neutropenia and prostate cancer among the conditions Dr. Benjamin treats.

CMS data shows 999 Medicare services from Dr. Benjamin across 7 procedure codes in 2024, for 209 Medicare patients. Medicare paid $90,381 for them.

CMS counts 209 Medicare patients who saw Dr. Benjamin in 2024. The largest group is 75 to 84, with 97 patients. 75% of them have cancer, and 75% have high blood pressure. 6% are also on Medicaid. Their average risk score is 2.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Benjamin's median patient age at 77, with 5% women.

In 2024, Dr. Benjamin wrote 901 Medicare Part D claims for 134 patients. 60% of them were for generic drugs. CMS names the drug for 761 of them, across 14 drugs with 11 or more claims each, at $3,139,869 in total drug cost. In 2023, CMS named 407 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Benjamin for performance year 2024, reported as part of a group. Dr. Benjamin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Benjamin as offering telehealth.

Dmand AI links 68 papers to Dr. Benjamin, published from 2011 to 2025. 2024 was the busiest year, with 18. The most frequent topics are Urinary Bladder Neoplasms, Carcinoma, Transitional Cell and Prostatic Neoplasms. Dr. Benjamin has published most often in BJU Int. Dr. Benjamin's most frequent co-authors are Arash Rezazadeh Kalebasty, MD, Omid Yazdanpanah, MD and Nataliya Mar, MD.

Dmand AI links Dr. Benjamin to 3 clinical trials, 2 of them phase 3 studies. 3 are still active or recruiting. Conditions studied include Prostatic Neoplasms, Urinary Bladder Neoplasms and Prostatic Diseases.

CMS Open Payments shows 88 general payments to Dr. Benjamin from 24 drug and device companies from 2022 to 2025. Speaker and faculty fees make up the largest share, 43% of the total. Merck KGaA paid the most, $27,436.

Dmand AI lists 2 awards for Dr. Benjamin, most recently Genitourinary Cancers Symposium Merit Award in 2022.

Dr. Benjamin graduated from Tulane School of Medicine in 2016. Dr. Benjamin is a member of ASCO.

Dr. Benjamin is in network with 5 carriers, including United Healthcare, Elevance and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 4. Check the plan with the practice before a visit.